Moody's Investors Service has affirmed the "Aa3" rating on San Diego-based Sharp HealthCare's long-term and underlying revenue bond ratings, affecting $545 million of rated debt.
The rating affirmation is based on several factors, including Sharp's improved balance sheet measures, ongoing strong operating performance and continued market share growth in San Diego County.
The outlook is stable, reflecting Moody's Investors Service's expectation that Sharp will continue to maintain is strong performance measures and healthy balance sheet.